BlossomHill Therapeutics, Inc. (BLSM)

NASDAQ: BLSM · Real-Time Price · USD

16.35

+0.11 (0.68%)

At close: Aug 13, 2026, 4:00 PM EDT

17.24

+0.89 (5.44%)

After-hours: Aug 13, 2026, 7:39 PM EDT

BlossomHill Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-71.09	-60.56	-30.7
Depreciation & Amortization	0.48	0.44	0.35
Stock-Based Compensation	1.18	1.09	0.5
Other Operating Activities	1.43	1.29	0.7
Change in Accounts Payable	3.88	1.47	-1.14
Change in Other Net Operating Assets	7.23	9.35	-1.13
Operating Cash Flow	-56.89	-46.93	-31.42
Operating Cash Flow Growth	-	-	-
Capital Expenditures	-0.68	-1.07	-0.09
Investing Cash Flow	-0.68	-1.07	-0.09
Issuance of Common Stock	0.82	0.59	0.42
Financing Cash Flow	84.76	84.53	17.56
Net Cash Flow	27.2	36.54	-13.95
Free Cash Flow	-57.56	-47.99	-31.51
Free Cash Flow Growth	-	-	-
Free Cash Flow Per Share	-23.15	-19.68	-13.76
Levered Free Cash Flow	-	-28.44	-
Unlevered Free Cash Flow	-	-28.44	-
Change in Working Capital	11.1	10.81	-2.27

SEC Filings: 10-K · 10-Q